Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted cyanoguanidines as oral anti-virals

Substituted cyanoguanidines as oral anti-virals

US Patent 10112911 · Granted Oct 30, 2018

Estimated economic value: $245,181,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or b2024
Anti-alpha-4-beta-7 antibodies2023
Compounds containing polysubstituted benzo[d][1,3]oxathiole, benzo[d][1,3]oxathi2022
Modulation of rice MPG1 activity to increase biomass accumulation, grain yield, 2022
Sustained-release injectable formulation2021
Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or b2021
Liquid precursor compositions and uses thereof for a ph-dependant sustained rele2020
N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,42020
Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of u2020
Inhibitors of tyrosine kinase 2 mediated signaling2019
Inhibitors of tyrosine kinase 2 mediated signaling2019
Sustained release delivery systems for the prevention and treatment of head and 2019